Ketogenic Diet for Treating Infantile Spasms: ½ year experience Mortensen M¹, Nielsen H¹, Povlsen JH¹, Johansen D¹, Daneman K¹, Miranda MJ¹ ¹Danish Epilepsy.

Slides:



Advertisements
Similar presentations
1 Chapter 40 The Epilepsies: Phenotypes and Mechanisms Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Advertisements

Seizure Disorders in Children
NEWLY DIAGNOSED EPILEPSY Treatment response in mesial temporal lobe epilepsy with hippocampal atrophy (N=14; 2.5% population) Non-responders (42%) Remission.
Advancing the Development of Pediatric Therapeutics (ADEPT) II: Evaluation of Long-term Neurocognitive Development in Pediatrics U.S. Food and Drug Administration.
Dr Tina Williams PLEAT Frimley Park Hospital June 2011.
CHAIRPERSON Dr. Mohammad Azizul Hoque Associate Professor Department of Pediatrics Mymensingh Medical College PRESENTER Dr. Md. Akhtaruzzaman MD 3 rd Part.
© 2014 Direct One Communications, Inc. All rights reserved. 1 Treating the New-Onset Epilepsy Patient Ching Y. Tsao, MD Emory University Hospital, Atlanta,
What to do IF Medications Fail? Dr Linda Huh Pediatric Neurologist BCCH.
Spike, generalized. Note the high amplitude, and the aftergoing background suppression and slow wave.
Funny Turns in Children Robert Jones, Paediatrician Andrew Smith, Senior Neurophysiology Technician.
Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures Andy Jagoda, MD, FACEP Professor of Emergency.
Autism and Epilepsy: A Comprehensive Medical Approach
Video-EEG Monitoring in Childhood Epilepsy
PSYC4080 Seizure Disorders 1. PSYC4080 Seizure Disorders 2  Abnormal electrical discharge in the brain.  Neurons firing together in synchrony: paroxysmal.
Anti Epileptic Drugs (AEDs) Sampath Charya, MD, FAAN, FAASM VAMC, Fayetteville, NC.
Neurological Outcomes (Epilepsy) in Clinical Trials for TSC and Related Disorders Working Group D International TSC Research Conference Summit on Drug.
Neurology Chapter of IAP
Study of epilepsy prevalence among pediatric patients in 48MH Dr. Noura Ali Noureldeen (MBBS, Arab Board)
Epilepsy In children with Cerebral Palsy Epilepsy In children with Cerebral Palsy By Dr. Asia Mulhi.
PKS Kids Family Weekend Friday, June 25, 2010 Francis Filloux, MD Meghan Candee, MD MS Division of Child Neurology, Department of Pediatrics, University.
© 2004 American Academy of NeurologyMay 20, 2004 Practice Parameter: Medical Treatment of Infantile Spasms Report of the American Academy of Neurology.
Definition of epilepsy
FONDE : A major new international research initiative (Marseille)
Management. First and most important question….. treat or don’t treat? →confirmed epilepsy? →trigger or provoking factors ? →bothersome? →Patients view.
Copyright restrictions may apply Intranasal Midazolam vs Rectal Diazepam for the Home Treatment of Acute Seizures in Pediatric Patients With Epilepsy Holsti.
New developments of Epileptic Syndromes in very young infants Raili Riikonen MD, PhD, Professor Kuopio University Hospital, Finland Baltimore
Objectives: Describe the clinical features and chromosomal abnormality of r (20). Explain the examination and tests used to diagnose r ( 20). Summarize.
LAFAYETTE HOME HOSPITAL: EPILEPSY; 2004 LAFAYETTE HOME HOSPITAL: EPILEPSY; 2004.
Febrile Convulsion Dr F. Ashrafzadeh 3/7/90.
Lennox Gastaut Syndrome Enrique Feoli MD North East Regional Epilepsy Group.
Epilepsy in Down’s Syndrome Dr Sameer Zuberi Paediatric Neurologist Fraser of Allander Neurosciences Unit Royal Hospital for Sick Children Glasgow.
Tuberous Sclerosis Abdullah M. Al-Olayan MBBS, SBP, ABP
Epilepsy in TSC Kevin C. Ess, MD, PhD Vanderbilt Children’s Hospital Vanderbilt Brain Institute Vanderbilt Center for Stem Cell Biology Vanderbilt University.
A Spanish collection of patients with Eslicarbazepine in clinical practice Serratosa J. 1, Guillamón E. 2, López-Gomáriz E. 3, Toledo M. 4, Salas J. 4,
Aim To identify common co-existing sleep disorders in childhood parasomnia and To assess sleep architecture in subgroup of children with parasomnia Introduction.
European Respiratory Society (ERS) International congress 2015 Amsterdam, Netherlands, 26–30 September PA1251 Session 123 Management of Asthma and other.
CDKL5 gene related epileptic encephalopathy in Estonia: a case presentation Klari Noormets 1,2, Katrin Õunap 2,3, Ulvi Vaher 1, Tiina Talvik 1,2, Inga.
Hypoxic-Ischaemic Encephalopathy (HIE) in Wales R Adappa.
Epilepsy Management Linda C. Ramatowski, NP Sutter Neuroscience.
Transition from Pediatric to Adult Care
Status Epilepticus Presenting After Traumatic Brain Injury in Infants Kurz, J. E.1; Zelleke, T.1; Carpenter, J.1; Dean, N.2; Singh, J.1; Kadom, N.3; Gaillard,
Benign infantile seizures are characterized by (1) familial or nonfamilial occurrence; (2) normal development prior to onset; (3) onset mostly during the.
Barbara Schmidt, Kristine Sandberg Knisely Chair in Neonatology
Infantile Spasms Mary L. Zupanc, MD, FAAP
Recognize and treat depression in epilepsy Maryam PoursadeghFard Shiraz University of Medical Science (1)Introduction: Depression is a major problem.
Frequently Asked Questions in Pediatric Epilepsy
Long term effectiveness of perampanel: the Leeds experience Jo Geldard, Melissa Maguire, Elizabeth Wright, Peter Goulding Leeds General Infirmary, Leeds.
Complications during Ketogenic Diet Initiation
Evidence of Morphologic Differences in Children with Down Syndrome who Develop Infantile Spasms. Nicholas Phillips1,3 , Asim Choudhri2, James Wheless1,
Outcomes after surgery, cortical resection, or hemispherectomy in infants with catastrophic focal epilepsy are very good. About 75–78% are seizure-free.
CBZ is the most common antiepileptic drug (AED) causing AED-induced seizure worsening. CBZ can both aggravate and induce new seizure types including absence,
Patients with IS caused by FCD frequently develop partial seizures that can precede, be simultaneous with, or follow the cluster of epileptic spasms. Spasms.
The causes of OS are symptomatic or organic; the causes of EME can be genetic, metabolic, or entirely unknown. OS causes tonic spasms and partial seizures.
Chapter 27 Epilepsy Overview Signs and symptoms
Ohtahara syndrome is a very rare and devastating form of epileptic encephalopathy of very early infancy. Onset of seizures is mainly by 1 month of age.
Childhood Epilepsies Dr. Anuruddha Padeniya Eisenhower Fellow 2012
Patients presenting with clinical features compatible with MAE but with seizure semiology consistent with focal seizure or focal abnormality seen in the.
EEG characteristics & yield in evaluation of first non-febrile seizure in children in Qatar Abdulhafeez M Khair, Khalid Ibrahim, Rana Alshami, Ahmed Veten,
ABSENCE SEIZURES.
Clinical pharmacology of antiseizure drugs
Aicardi Syndrome Crystal Kahahane.
Pediatric Antiepileptic Treatment Strategies
Epilepsy Treatment Across the Spectrum
Figure 2 Cumulative proportion of patients experiencing a seizure recurrence after randomization, comparing immediate vs deferred treatment Cumulative.
Figure 3 Possible modalities for reconciliation of patient's and physician's report of symptomatic treatment-associated toxicities Figure 3 | Possible.
Expert Perspectives in the Recognition and Management of Lennox-Gastaut Syndrome.
Skills Workshop | Genetics Testing in Epilepsy Patients
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Acute and Chronic Seizures in Patients Older Than 60 Years
Childhood Epilepsies Dr. Anuruddha Padeniya Eisenhower Fellow 2012
Presentation transcript:

Ketogenic Diet for Treating Infantile Spasms: ½ year experience Mortensen M¹, Nielsen H¹, Povlsen JH¹, Johansen D¹, Daneman K¹, Miranda MJ¹ ¹Danish Epilepsy Centre, Dianalund, Denmark Introduction Infantile spasms (IS) are a severe epilepsy syndrome in early childhood with a variety of aetiologies IS have a high morbidity and are difficult to treat¹ Cessation of spasms by early and appropriate treatment is essential for improving outcome Ketogenic Diet (KD) has been successfully used for treating medically refractory IS² ³ Aim To evaluate the effectiveness of KD for treating medically refractory IS, regarding tolerability and seizure reduction (retrospective study). Patients and methods Retrospective study of the first 8 infants treated with KD All infants had previously been treated with Vigabatrin, Hydrocortisone and a mean of 5 (3-7) antiepileptic drugs (AEDs) (VPA, TPM, LEV, Zonisamide, benzodiazepines). Table 2 - Results Table 1 - Patient data Table 3 - The Ketogenic Diet r References Conclusions KD has shown to be an effective and safe treatment for medically refractory IS The clinical response is positive (measured by reduction or cessation of spasms) in most infants (7/8) and the tolerability good (8/8) Reduction (6/8)/ interruption (2/8) of AEDs is an additional positive effect We can not conclude on EEG improvement in this study Cur rent Age (mo) Gen -der DiagnosisEpilepsy onset (mo) Diet start (mo) EEG before KD 119F Cryptogenic West Syndrome 410 Hypsarritmia 222M Symptomatic West Syndrome (Deletion 22q13) 916 Hypsarritmia 318M Symptomatic West Syndrome (Trisomy 21-Down S.) 512 Hypsarritmia 418F Early Myoclonic Encephalopathy 612 Suppression-burst 518M Cryptogenic West Syndrome 413 Multifocal 616M Symptomatic West Syndrome (Multiple cerebral malformations) 212 Multifocal 725M Cryptogenic West Syndrome 321 Hypsarritmia 818M Cryptogenic West Syndrome 315 Hypsarritmia Seizures before KD (mean/week) Seizures after 1 mo (mean/week) Seizures after 3 mo (mean/week) Seizures after 6 mo (mean/week) Total Seizure reduction EEG at follow-up % Multifocal % n/a out of diet10 % Hypsarritmia % Slight improvement n/a86 % n/a* n/a68 % n/a* n/a66 % n/a* n/a50 % Multifocal Diet start Kcal / Ratio / Carbsxday Diet after 1 mo Kcal / Ratio / Carbsx day Diet after 3 mo Kcal / Ratio / Carbsxday Diet after 6 mo Kcal / Ratio / Carbsxday 1720 / 4:1 / 5,5 g 750 / 4:1 / 5,5 g860 / 4:1 / 5,5 g 2550 / 4:1 / 2 g700 / 3,5:1 / 5 g 810 / 3,5:1 / 5 g 3550 / 4:1 / 2,3 g580 / 4:1 / 2,4 g680 / 4:1 / 2,8 gout of diet 4450 / 3:1 / 1,8 g525 / 3:1 / 2,1 g565 / 3:1 / 2,1 g610 / 4:1 /2,3 g 5600 / 3:1 / 4 g 600 / 4:1 / 4 gn/a* 6700 / 4:1 / 4 g600 / 4:1 / 3 g450 / 4:1 / 3 gn/a* 7700 / 4:1 / 5 g n/a* 8565 / 3:1 / 3,5 g605 / 3:1 / 3,5 g617 / 4:1 / 2,5 gn/a* *n/a= non available References: ¹Cochrane Database Syst Rev 2002; ²Kossoff EH, Pediatrics 2002; ³Eun SH et al, Brain Dev 2006 Patient 1